Inventor

MERTENS KOENRAAD

NL11 patents

⚠️ This page may combine multiple inventors who share the name “MERTENS KOENRAAD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SANQUIN BLOEDVOORZIENING

4 patents

US6083905AJul 4, 2000

Method and means for detecting and treating disorders in the blood coagulation cascade

SANQUIN BLOEDVOORZIENING92 citations94

US6919311B2Jul 19, 2005

Factor VII polypeptide having factor VII:C activity

SANQUIN BLOEDVOORZIENING33 citations91

US7544660B2Jun 9, 2009

Factor VIII polypeptide having factor VIII:C activity

SANQUIN BLOEDVOORZIENING3 citations61

USRE38202EJul 22, 2003

Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein

SANQUIN BLOEDVOORZIENING4 citations60

NOVO NORDISK AS

2 patents

US10906960B2Feb 2, 2021

Factor VIII variants having a decreased cellular uptake

NOVO NORDISK AS0 citations56

US10047142B2Aug 14, 2018

Factor VIII variants having a decreased cellular uptake

NOVO NORDISK AS0 citations45

STICHTING CENTRAAL LAB

1 patent

US5932706AAug 3, 1999

Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein

STICHTING CENTRAAL LAB9 citations70

STICHING CENTRAAL LAB VAN DE B

1 patent

US6284871B1Sep 4, 2001

Factor IX binding peptides, derived from factor VIII and their use as inhibitors of blood coagulation

STICHING CENTRAAL LAB VAN DE B13 citations69

LENTING PETRUS JOHANNES

1 patent

US8546332B2Oct 1, 2013

Factor VIII polypeptide having factor VIII:C activity

LENTING PETRUS JOHANNES0 citations44

MERTENS KOENRAAD

1 patent

US8586538B2Nov 19, 2013

Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII

MERTENS KOENRAAD0 citations39

MEEMS HENRIET

1 patent

US9321827B2Apr 26, 2016

Factor VIII variants having a decreased cellular uptake

MEEMS HENRIET0 citations37